Literature DB >> 1202605

Rheumatoid synovitis: complement and immune complexes.

P H Schur, M C Britton, A E Franco, J M Corson, J L Sosman, S Ruddy.   

Abstract

The pattern of complement component utilization within the joint space of patients with RA is consistent with activation by immune complexes. Immunogluorescent studies of SF leukocytes revealed intracytoplasmic inclusions of immunoglobulins and complement components, particularly in cells from SF with low complement levels and containing materials which precipitated with either C1q and/or rheumatoid factor. RA patients with low levels of SF complement tended to have an unremitting course, subcutaneous nodules, and to have been treated with gold. Their joints had more periarticular demineralization, joint space narrowing, cortical impaction by X-ray; and synoviocytic giant cells, fibrosis, lymphocytes, congestion, and fibrin exudation by pathologic examination than did joints of RA patients without low levels of SF complement. Patients with systemic hypocomplementemia had active classical RA with evidence of severe joint involvement and vasculitis. These findings suggest that rheumatoid inflammation of joints is mediated by immunologic activation of the complement system.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1202605

Source DB:  PubMed          Journal:  Rheumatology        ISSN: 0080-2727            Impact factor:   7.580


  6 in total

1.  Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis.

Authors:  Altan Ercan; Jing Cui; Dereck E W Chatterton; Kevin D Deane; Melissa M Hazen; William Brintnell; Colin I O'Donnell; Lezlie A Derber; Michael E Weinblatt; Nancy A Shadick; David A Bell; Ewa Cairns; Daniel H Solomon; V Michael Holers; Pauline M Rudd; David M Lee
Journal:  Arthritis Rheum       Date:  2010-08

2.  Lack of hidden complement fixing IgM rheumatoid factor in adult seronegative rheumatoid arthritis.

Authors:  D L Robbins; T L Moore
Journal:  Ann Rheum Dis       Date:  1980-02       Impact factor: 19.103

3.  A novel anti-inflammatory role for secretory phospholipase A2 in immune complex-mediated arthritis.

Authors:  Eric Boilard; Ying Lai; Katherine Larabee; Barbara Balestrieri; Farideh Ghomashchi; Daisuke Fujioka; Reuben Gobezie; Jonathan S Coblyn; Michael E Weinblatt; Elena M Massarotti; Thomas S Thornhill; Maziar Divangahi; Heinz Remold; Gérard Lambeau; Michael H Gelb; Jonathan P Arm; David M Lee
Journal:  EMBO Mol Med       Date:  2010-05       Impact factor: 12.137

Review 4.  Mast cells in inflammatory arthritis.

Authors:  Peter A Nigrovic; David M Lee
Journal:  Arthritis Res Ther       Date:  2004-11-02       Impact factor: 5.156

5.  Complement C3c as a biomarker in heart failure.

Authors:  A Frey; G Ertl; C E Angermann; U Hofmann; S Störk; S Frantz
Journal:  Mediators Inflamm       Date:  2013-12-30       Impact factor: 4.711

Review 6.  Rheumatoid factor, complement, and mixed cryoglobulinemia.

Authors:  Peter D Gorevic
Journal:  Clin Dev Immunol       Date:  2012-08-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.